Blog

Drew Moghanaki shared a study from Duke University on Stage I NSCLC

Photo taken from Drew Moghanaki/X

Jan 8, 2024, 14:21

Drew Moghanaki shared a study from Duke University on Stage I NSCLC

Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on X/Twitter:

“An interdisciplinary group at Duke University recently compared the time to treatment for patients with Stage I Non-Small Cell Lung Cancer, who undergo a thoracic surgery evaluation or not.

At UCLA, the thoracic surgery team is spectacular at expediting work up to minimize the time it takes to start Body Radiotherapy (SBRT). (Not a typo)”

Read further.

Source: Drew Moghanaki/X

cancer Drew Moghanaki Duke University Lung cancer non small cell lung cancer NSCLC OncoDaily Oncology SBRT Stereotactic Body Radiotherapy UCLA Health Jonsson Cancer Center

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage